Skyline’s business strategy is to evolve a broad portfolio of genomics-based diagnostic tests and to commercialize these products on a global scale.
Therefore, it is key to Skyline to form partnerships with pharma and biotech companies, as well as with academic and non-academic organizations, and to collaborate on development of new IVDs.
Tailoring therapy based on genetic profiles of individual patients in order to maximize therapeutic response and to prevent adverse side-effects are essential to optimize modern health care. Skyline has all relevant expertise and know-how to discover genetic markers or signatures of clinical relevance and to develop these into practical and...Read more >>
Skyline Diagnostics is a leading company in developing genetic biomarkers to reliable diagnostic assays of high clinical relevance.Read more >>
Rotterdam Science Tower, Marconistraat 16, 3029 AK Rotterdam. The Netherlands, Europe. Phone: +31 (0)10 7038410. Fax: +31 (0)10 7043076. E-mail: email@example.com